Louise Ziegler

Publikationer
CV
Populärvetenskap och samverkan

Utvalda publikationer

Article: CARDIOVASCULAR RESEARCH (CVR). 2023;119(16):2594-2606
A machine learning based approach to identify carotid subclinical atherosclerosis endotypes
Chen QS; Bergman O; Ziegler L; Baldassarre D; Veglia F; Tremoli E; Strawbridge RJ; Gallo A; Pirro M; Smit AJ; Kurl S; Savonen K; Lind L; Eriksson P; Gigante B
Article: JOURNAL OF MEDICAL VIROLOGY. 2021;93(10):5908-5916
Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers
Lundstrom A; Ziegler L; Havervall S; Rudberg A-S; von Meijenfeldt F; Lisman T; Mackman N; Sanden P; Thalin C

Artiklar

Journal article: EUROPEAN HEART JOURNAL. 2024;45(Supplement_1):ehae666.2619
Interaction between subclinical carotid atherosclerosis endotype and biological sex: a study from IMPROVE cohort
Chen Q; Bergman O; Ziegler L; Baldassarre D; Tremoli E; Strawbridge R; Eriksson P; Gigante B
Article: PSYCHONEUROENDOCRINOLOGY. 2024;164:107008
A novel biomarker of interleukin 6 activity and clinical and cognitive outcomes in depression
Foley EM; Slaney C; Donnelly NA; Kaser M; Ziegler L; Khandaker GM
Journal article: BRAIN, BEHAVIOR, AND IMMUNITY. 2023;114:44
A novel marker of interleukin 6 activity and clinical and cognitive outcomes in depression
Foley EM; Slaney C; Kaser M; Ziegler L; Khandaker G
Journal article: ALZHEIMER'S AND DEMENTIA. 2023;19(S8)
Temporal trends in the incidence of atrial fibrillation‐related strokes in Sweden, 2001‐2020
Ding M; Wennberg AM; Ziegler LD; Modig K
Article: THE LANCET REGIONAL HEALTH. EUROPE. 2023;28:100596
Time trends in atrial fibrillation-related stroke during 2001-2020 in Sweden: a nationwide, observational study
Ding M; Ebeling M; Ziegler L; Wennberg A; Modig K
Journal article: NEUROSCIENCE APPLIED. 2023;2:102449
A novel marker of interleukin 6 activity and clinical and cognitive outcomes in depression
Foley ÉM; Slaney C; Kaser M; Barnes NM; Ziegler L; Khandaker GM
Article: CYTOKINE. 2022;159:156020
IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in Sweden
Ziegler L; Lundstrom A; Havervall S; Thalin C; Gigante B
Journal article: EUROPEAN HEART JOURNAL. 2021;42(Supplement_1):ehab724.2510
IL6 trans-signalling is associated with a higher risk of cardiovascular events in individuals with diabetes
Ziegler L; Gigante B
Article: OPEN HEART. 2021;8(2):e001694
Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and women
Miri Y; Leander K; Eriksson P; Gigante B; Ziegler L
Article: BMC NEUROLOGY. 2021;21(1):306
IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation
Ziegler L; Wallen H; Aspberg S; de Faire U; Gigante B
Article: VASCULAR MEDICINE. 2021;26(1):3-10
Expression of Interleukin 6 signaling receptors in carotid atherosclerosis
Ziegler L; Lundqvist J; Dreij K; Wallen H; de Faire U; Paulsson-Berne G; Hedin U; Matic L; Gigante B
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (EJPC). 2020;27(2):122-129
The predictive role of interleukin 6 trans-signalling in middle-aged men and women at low-intermediate risk of cardiovascular events
Ziegler L; Frumento P; Wallen H; de Faire U; Gigante B
Journal article: EUROPEAN HEART JOURNAL. 2019;40(Supplement_1):ehz748.0281
P1519IL6 trans-signalling affects risk of cardiovascular events pre-eminently in men
Ziegler L; Frumento P; Wallen H; De Faire U; Gigante B
Article: BMC GERIATRICS. 2019;19(1):31
Temporal trends in incidence, recurrence and prevalence of stroke in an era of ageing populations,a longitudinal study of the total Swedish population
Modig K; Talback M; Ziegler L; Ahlbom A
Article: CARDIOVASCULAR RESEARCH (CVR). 2019;115(1):213-221
Interleukin 6 trans-signalling and risk of future cardiovascular events
Ziegler L; Gajulapuri A; Frumento P; Bonomi A; Wallen H; de Faire U; Rose-John S; Gigante B
Journal article: EUROPEAN HEART JOURNAL. 2018;39(suppl_1):ehy565.p2625
P2625The soluble IL6 receptor and ischemic cerebrovascular disease
Ziegler L; Lundqvist J; Perisic L; Gajulapuri A; Dreij K; Frumento P; Paulsson-Berne G; Wallen H; De Faire U; Hedin U; Gigante B
Journal article: REVUE D'EPIDEMIOLOGIE ET DE SANTE PUBLIQUE. 2018;66:s366
Incidence, recurrence and prevalence of stroke in an ageing population
Modig K; Ahlbom A; Talback M; Ziegler L
Journal article: EUROPEAN HEART JOURNAL. 2017;38(suppl_1):ehx504.4159
4159The soluble IL6 receptor as a predictor for early cardiovascular events
Ziegler L; Gajulapuri A; Frumento P; Wallen H; De Faire U; Gigante B

Alla övriga publikationer

Corrigendum: BMC NEUROLOGY. 2022;22(1):337
IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation (vol 21, 306, 2021)
Ziegler L; Wallen H; Aspberg S; de Faire U; Gigante B
Review: EUROPEAN CARDIOLOGY REVIEW. 2022;17:e09
Circulating Biomarkers in Lower Extremity Artery Disease
Ziegler L; Hedin U; Gottsater A
Preprint: SSRN ELECTRONIC JOURNAL. 2022
Time Trends in Atrial Fibrillation-Related Stroke in an Era of Declining Stroke - A Swedish Nationwide Register-Based Study
Ding M; Ebeling M; Ziegler L; Wennberg A; Modig K
Preprint: MEDRXIV. 2021
Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers
Lundström A; Ziegler L; Havervall S; Rudberg A-S; von Meijenfeldt F; Lisman T; Mackman N; Sandén P; Thålin C
Conference publication: EUROPEAN HEART JOURNAL. 2021;42:2510
IL6 trans-signalling is associated with a higher risk of cardiovascular events in individuals with diabetes
Ziegler L; Gigante B
Conference publication: EUROPEAN HEART JOURNAL. 2020;41:2365
IL6 trans-signalling associates with atherothrombotic but not with cardioembolic stroke
Ziegler L; Wallen H; Aspberg S; De Faire U; Gigante B
Thesis / dissertation: 2020
Interleukin 6 trans-signalling : cardiovascular risk marker or therapeutical target?
Ziegler, Louise
Conference publication: INTERNATIONAL JOURNAL OF STROKE. 2020;15(1_SUPPL):50
PRO-INFLAMMATORY IL6 TRANS-SIGNALLING IS ASSOCIATED WITH ISCHEMIC STROKE BUT NOT WITH ATRIAL FIBRILLATION
Ziegler L
Conference publication: EUROPEAN HEART JOURNAL. 2019;40:824
IL6 trans-signalling affects risk of cardiovascular events pre-eminently in men
Ziegler L; Frumento P; Wallen H; De Faire U; Gigante B
Conference publication: EUROPEAN HEART JOURNAL. 2018;39:524-525
The soluble IL6 receptor and ischemic cerebrovascular disease
Ziegler L; Lundqvist J; Perisic L; Gajulapuri A; Dreij K; Frumento P; Paulsson-Berne G; Wallen H; De Faire U; Hedin U; Gigante B
Conference publication: EUROPEAN HEART JOURNAL. 2017;38:857
The soluble IL6 receptor as a predictor for early cardiovascular events
Ziegler L; Gajulapuri A; Frumento P; Wallen H; De Faire U; Gigante B

Anställningar

Överläkare, Internmedicin och vaskulär medicin, Neurologkliniken, Danderyds sjukhus, 2024-
Anknuten till Forskning, Kliniska vetenskaper, Danderyds sjukhus, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för kliniska vetenskaper, Danderyds sjukhus, Karolinska Institutet, 2020

Utvalda publikationer

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI